[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356702-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356702-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","assessing-diagnostic-accuracy-of-circulating-micrornas-as-biomarkers-for-ovarian-cancer-a-systematic-review-and-meta-analysis","Assessing diagnostic accuracy of circulating microRNAs as biomarkers for ovarian cancer - a systematic review and meta-analysis","","Ovarian cancer is among the deadliest gynecological malignancies due to silent progression and limited effectiveness of conventional early-detection methods. Circulating microRNAs (miRNAs) are explored as non-invasive diagnostic biomarkers because they remain stable in biofluids and show tumor-associated expression signatures. A systematic review and meta-analysis following PRISMA-DTA guidelines searched PubMed, EMBASE, and Web of Science through March 8, 2025, identifying 24 eligible studies and pooling diagnostic performance metrics using a bivariate random-effects model.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/assessing-diagnostic-accuracy-of-circulating-micrornas-as-biomarkers-for-ovarian-cancer-a-systematic-review-and-meta-analysis/356702/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/assessing-diagnostic-accuracy-of-circulating-micrornas-as-biomarkers-for-ovarian-cancer-a-systematic-review-and-meta-analysis/356702.png","ImageObject",300,407,{"name":42,"@type":43},"Sarah ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are circulating microRNAs considered for ovarian cancer diagnosis?","Question",{"text":63,"@type":64},"Circulating microRNAs are stable in biofluids and their expression patterns correlate with tumors, making them promising non-invasive diagnostic biomarkers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the evidence synthesized in the study?",{"text":68,"@type":64},"The review followed PRISMA-DTA guidelines and searched PubMed, EMBASE, and Web of Science up to March 8, 2025, then pooled sensitivity, specificity, likelihood ratios, and diagnostic odds ratio using a bivariate random-effects model.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the meta-analysis conclude about diagnostic performance?",{"text":72,"@type":64},"The combined sensitivity, specificity, and diagnostic odds ratio indicated moderate-to-high diagnostic efficacy, with serum-based tests showing a higher diagnostic odds ratio than PBMC-based tests.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356702,1790922573,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Iqbal et al. Journal of Ovarian Research (2026) 19:168 Journal of Ovarian Research  \n[https://doi.org/10.1186/s13048-026-02067-0](https://doi.org/10.1186/s13048-026-02067-0)  \nREVIEW Open Access  \nAssessing diagnostic accuracy of circulating  microRNAs as biomarkers for ovarian cancer: a systematic review and meta-analysis  \nMuhammad Omer Iqbal 1†, Ashfaq Ahmad Shah Bukhari2, Awais Ali3†, Yuchao Gu1, Jin Chen1* and Bingqiang Zhang4*  \nAbstract  \nOvarian cancer is one of the deadliest gynecological malignancies, mainly because of its silent development and the lack of effective conventional methods for diagnosis. Because of their extraordinary stability in bio fluids and expression signatures that specifically correlate with tumors, circulating microRNAs (miRNAs) have received much attention as non-invasive diagnostic biomarkers. This meta-analysis evaluates the diagnostic value of circulating miRNAs for early ovarian cancer. A systematic literature review was performed in line with PRISMA-DTA guidelines in PubMed, EMBASE, and Web of Science until March 8, 2025. A total of 24 studies were eligible. Pooled diagnostic metrics (sensitivity and specificity, likelihood ratios, and diagnostic odds ratio (DOR)) were calculated based upon the bivariate random effect model. Summary receiver operating characteristic (sROC) curves were generated and subgroup and meta-regression analyses performed to investigate heterogeneity. Sensitivity analyses were performed to assess the strength of the pooled estimates. The combined sensitivity, specificity and DOR was 0.749 (95% CI: 0.702–0. 791), 0.748 (95% CI:0 .695–0. 794) and 8.403 (95% CI: 6.308–11. 194) respectively, which means a moderate-to-high diagnostic efficacy. Screening efficacy of serum-based and PBMC-based tests differed significantly at the DOR of 10.55 being maximum amongst serum assays. Biospecimen and regional differences contributed substantially to heterogeneity. The results were robust according to sensitivity analyses, and there was no obvious publication bias based on Deeks’ test (p = 0 . 08) . Circulating miRNAs, especially serum-based profiles, are highly promising as non-invasive diagnosis in ovarian cancer. Standardization of protocols and prospective validation is necessary for clinical application.  \nKeywords Ovarian cancer, miRNAs, Biomarkers, Liquid biopsy  \n†Muhammad Omer Iqbal and Awais Ali contributed equally to this work.  \n*Correspondence:  \nJin Chen[chenjin110@zju.edu.cn](chenjin110@zju.edu.cn)[ ](chenjin110@zju.edu.cn)Bingqiang Zhang [zhangbq@ruisidechina.com](zhangbq@ruisidechina.com)  \n1College of Biological Engineering, Qingdao University of Science and Technology, Qingdao 266003, China  \n2Department of Physiology, RAK College of Medical Sciences, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, UAE 3State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjin Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450052, China  \n4Qingdao Restore Biotechnology Co., Ltd, Qingdao, Shandong 266111, PR China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulatio","cbCaiqIFJbOTwneW","https://ap.wps.com/l/cbCaiqIFJbOTwneW","pdf",2750506,11,"English","# Abstract\n# Introduction\n# Simple summary","[{\"question\":\"Why are circulating microRNAs considered for ovarian cancer diagnosis?\",\"answer\":\"Circulating microRNAs are stable in biofluids and their expression patterns correlate with tumors, making them promising non-invasive diagnostic biomarkers.\"},{\"question\":\"How was the evidence synthesized in the study?\",\"answer\":\"The review followed PRISMA-DTA guidelines and searched PubMed, EMBASE, and Web of Science up to March 8, 2025, then pooled sensitivity, specificity, likelihood ratios, and diagnostic odds ratio using a bivariate random-effects model.\"},{\"question\":\"What did the meta-analysis conclude about diagnostic performance?\",\"answer\":\"The combined sensitivity, specificity, and diagnostic odds ratio indicated moderate-to-high diagnostic efficacy, with serum-based tests showing a higher diagnostic odds ratio than PBMC-based tests.\"}]","Assessing diagnostic accuracy of circulating microRNAs as biomarkers for ovarian cancer - a systematic review and meta-analysis | PDF",1790126864,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d6ed70dbde5d7f71aa45f842a2472e6.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01dbefd79a82e6a6152e0fa773e35c71.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aca3c327bf12d8c6dd31ceca33a9dde8.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7daa37521ba47169ed6dcbc72a0d9135.webp",980,1306]